Premium
Keros Therapeutics Inc (KROS)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candida... Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis. Show more
Keros will host an update call and webcast today, December 12, 2024, at 8:00 a.m. ET LEXINGTON, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”...
Elritercept demonstrated a durable transfusion independence in lower-risk myelodysplastic syndromes, including in patients with high transfusion burden, with a median duration of response of 134.1...
Keros Therapeutics to receive upfront payment of $200 million and is eligible to receive development, approval and commercial milestone payments with the potential to exceed $1.1 billion and...
LEXINGTON, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -46.505 | -72.1511131797 | 64.455 | 72.37 | 15.67 | 3258224 | 24.19758948 | CS |
| 4 | -41.84 | -69.9782572337 | 59.79 | 72.37 | 15.67 | 1175234 | 33.39563385 | CS |
| 12 | -39.33 | -68.6627094972 | 57.28 | 72.37 | 15.67 | 627227 | 44.15563853 | CS |
| 26 | -30.85 | -63.2172131148 | 48.8 | 72.37 | 15.67 | 486572 | 45.87343688 | CS |
| 52 | -11.89 | -39.845844504 | 29.84 | 73 | 15.67 | 433906 | 49.8200929 | CS |
| 156 | -35.69 | -66.5361670395 | 53.64 | 73 | 15.67 | 282799 | 45.78355307 | CS |
| 260 | -2.15 | -10.6965174129 | 20.1 | 88.8 | 15.67 | 231325 | 46.99826116 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
